Quick answer
NSAIDs (ibuprofen, naproxen, ketorolac) is typically detectable in urine for no relevant interference on current assays after any use. It is not part of standard employment panels.
Not screened on standard employment panels.
Typical cutoff: Never screened; 1990s-era cannabinoid cross-reactivity eliminated in modern assays.
Detection window by test type
| urine | |
|---|---|
| Any use | no relevant interference on current assays |
| saliva | |
| Any use | n/a |
| hair | |
| Any use | n/a |
| blood | |
| Any use | n/a |
Ranges reflect typical published detection windows and vary with dose, frequency, body composition, hydration and the assay used.
Key details
Ibuprofen and naproxen cannot fail a modern drug test. The famous 'ibuprofen false positive for marijuana' finding dates to 1990s-era assays and was engineered out of contemporary immunoassays; confirmation testing closes any residual loop.
Take your normal pain relief before testing — skipping NSAIDs changes nothing about results.
Frequently asked questions
How long does nsaids (ibuprofen, naproxen, ketorolac) stay in your system?
In urine, typical detection is no relevant interference on current assays (any use). Hair can detect use for up to 90 days and saliva/blood windows are usually shorter.
Will nsaids (ibuprofen, naproxen, ketorolac) show up on a standard drug test?
No — NSAIDs (ibuprofen, naproxen, ketorolac) is not part of the standard 5-, 10- or 12-panel or DOT tests. It would require a specialised or expanded assay.
How accurate are these detection windows?
They are typical ranges from published literature and assay documentation, not guarantees. Clearance depends on dose, frequency, metabolism and the specific test cutoff used.
Related substances
Cite this page
DrugPanels. “NSAIDs (ibuprofen, naproxen, ketorolac) Detection Time.” https://drugpanels.com/detection/nsaids/. Accessed 2026-09-10.
Sources
- Brahm NC et al., Commonly prescribed medications and potential false-positive drug test results, Mayo Clinic Proceedings 2008 — Mayo Clinic Proceedings — pubmed.ncbi.nlm.nih.gov
- Immunoassay cross-reactivity and validation documentation (FDA 510(k) summaries) — U.S. Food and Drug Administration — accessdata.fda.gov
Detection windows describe typical ranges from the published literature and assay documentation; individual results vary. See our methodology.